• Citer

Efficacy of adjuvant trastuzumab for patients with human epidermal growth factor receptor 2-positive early breast cancer and tumors ≤ 2 cm: A meta-analysis of the randomized trastuzumab trials

par O'Sullivan, Ciara C.C.;Zardavas, Dimitros ;Ballman, Karla K.V.;Holmes, Eileen;de Azambuja, Evandro ;Piccart-Gebhart, Martine ;Zujewski, Jo Anne;Gelber, Richard R.D.;Bradbury, Ian;Campbell, Christine;Spielmann, Marc;Perez, Edith A;Joensuu, Heikki;Costantino, Joseph P;Delaloge, Suzette;Rastogi, Priya
Référence Journal of clinical oncology, 33, 24, page (2600-2608)
Publication Publié, 2015-08

Article révisé par les pairs

• Détails
• Contenu

Titre:	Efficacy of adjuvant trastuzumab for patients with human epidermal growth factor receptor 2-positive early breast cancer and tumors ≤ 2 cm: A meta-analysis of the randomized trastuzumab trials
Auteur:	O'Sullivan, Ciara C.C.; Zardavas, Dimitros; Ballman, Karla K.V.; Holmes, Eileen; de Azambuja, Evandro; Piccart-Gebhart, Martine; Zujewski, Jo Anne; Gelber, Richard R.D.; Bradbury, Ian; Campbell, Christine; Spielmann, Marc; Perez, Edith A; Joensuu, Heikki; Costantino, Joseph P; Delaloge, Suzette; Rastogi, Priya
Informations sur la publication:	Journal of clinical oncology, 33, 24, page (2600-2608)
Statut de publication:	Publié, 2015-08
Sujet CREF:	Cancérologie
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.2015.60.8620
	info:scp/84940512225